Results 111 to 120 of about 160,652 (313)
Arthritis &Rheumatology, EarlyView.Objective Individuals with systemic autoimmune rheumatic diseases (SARDs) are at risk for worse acute and post–acute COVID‐19 outcomes, though whether individuals with SARDs have longer persistence of viral antigens after COVID‐19 has not been studied.
Naomi J. Patel +18 more
wiley +1 more source
Lupus-related vasculitis in a cohort of systemic lupus erythematosus patients
The Turkish Journal of Gastroenterology, 2021 Objectives: This study aims to examine the frequency and clinical association of lupus-related vasculitis in patients with systemic lupus erythematosus (SLE).
Sherif M Gamal +5 more
doaj
From Interferon Signature to the Clinical Landscape: Type I Interferonopathies
Arthritis &Rheumatology, EarlyView.Objective TypeI interferonopathies are heterogeneous diseases driven by dysregulated type I interferon (IFN‐I) signaling. Diagnosis is challenging due to clinical/molecular variability and the need for IFN‐I quantification. The aim of this study was to characterize the clinical, immunologic, genetic, molecular profiles of patients with suspected ...
Ismail Yaz +13 more
wiley +1 more source
Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab
Kidney International Reports, 2020 Noah Huizenga +5 more
doaj +1 more source
Arthritis &Rheumatology, EarlyView.Objective Somatic DNMT3A mutations are the most common drivers of clonal hematopoiesis in patients with rheumatoid arthritis (RA) and have been associated with seropositive disease and increased markers of inflammation. These mutations are predominantly hypomorphic or dominant‐negative, reducing DNMT3A function.
Yunbing Shen +10 more
wiley +1 more source
British Journal of Hospital Medicine, 2014 The systemic vasculitides are uncommon but serious diseases. Early recognition can be difficult because they mimic many conditions. Aggressive immunosuppression is toxic but effective; a targeted approach with biological agents may improve the outcome.
openaire +3 more sources
Arthritis &Rheumatology, Accepted Article.Objective We evaluated baseline characteristics, treatment patterns, and outcomes in patients with systemic autoimmune rheumatic disease‐associated progressive pulmonary fibrosis (SARD‐PPF) and evaluated whether outcomes differed by SARD subtype. Methods The ILD‐PRO Registry is a prospective multicenter US registry of patients with PPF.
Sonali J Bracken +7 more
wiley +1 more source
Treatment of Pediatric Vasculitis
, 2017 My thesis discusses the 3 most common types of pediatric vasculitis, Henoch-Schonlein purpura, Kawasaki disease and Polyarteritis nodosa including the etiology, epidemiology, clinical manifestations and the general and specific treatment, with regard to ...
Elias, Adeeb
core
Assessment of Disease Activity in Large-vessel Vasculitis
, 2017 Objective. To arrive at consensus for candidate outcomes for disease activity assessment in large-vessel vasculitis (LVV) in clinical trials. Methods.
DİRESKENELİ, RAFİ HANER
core +1 more source
Arthritis &Rheumatology, EarlyView.Objective Although Takayasu arteritis (TAK) is not a prototypical autoantibody‐mediated disease, accumulating evidence suggests that B cells are involved. This study aimed to investigate the pathway of B cell activation and its contributions to TAK pathogenesis. Methods Histologic analysis of paravascular lymph nodes and affected arteries was conducted
Chenglong Fang +10 more
wiley +1 more source